Skip to main navigation Skip to search Skip to main content

Adjuvant therapy for esophageal squamous cell carcinoma

  • Sungkyunkwan University

Research output: Contribution to journal › Article › peer-review

Abstract

Adjuvant therapy for completely resected esophageal squamous cell carcinoma is less commonly applied in clinical practice than neoadjuvant therapy, but it plays a substantial role in improving survival for esophageal cancer patients. This article presents a concise review of the evidence regarding adjuvant therapy for esophageal squamous cell carcinoma and future directions, particularly immunotherapy.

Original languageEnglish
Pages (from-to)168-171
Number of pages4
JournalKorean Journal of Thoracic and Cardiovascular Surgery
Volume53
Issue number4
DOIs
StatePublished - 1 Aug 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adjuvant therapy
  • Esophageal neoplasms
  • Immunotherapy
  • Neoadjuvant therapy

Fingerprint

Dive into the research topics of 'Adjuvant therapy for esophageal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this